An improved and simplified method of detecting the acetylator phenotype.
作者信息
Evans D A
出版信息
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
Abstract
摘要
相似文献
1
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
2
The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.在捷克斯洛伐克使用磺胺二甲嘧啶测定结核病患者的乙酰化酶表型。
Tubercle. 1973 Mar;54(1):67-71. doi: 10.1016/0041-3879(73)90016-0.
3
A qualitative test for the determination of isoniazid acetylator phenotype.一种用于测定异烟肼乙酰化酶表型的定性试验。
Indian J Med Res. 1978 Aug;68:335-40.
4
Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotyping.
Int J Clin Pharmacol Ther Toxicol. 1984 Dec;22(12):646-7.
5
Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.接受异烟肼治疗的快乙酰化和慢乙酰化患者的抗核因子
J Med Genet. 1972 Mar;9(1):53-6. doi: 10.1136/jmg.9.1.53.
6
Determination of the acetylator phenotype using matrix isoniazid.使用基质异烟肼测定乙酰化表型。
Tubercle. 1975 Sep;56(3):203-9. doi: 10.1016/0041-3879(75)90053-7.
7
Sulphadimidine acetylation test for classification of patients as slow or rapid inactivators of isoniazid.用于将患者分类为异烟肼慢灭活者或快灭活者的磺胺二甲嘧啶乙酰化试验。
Br Med J. 1970 Aug 29;3(5721):495-7. doi: 10.1136/bmj.3.5721.495.
8
Acetylator phenotypes in Papua New Guinea.巴布亚新几内亚的乙酰化表型。
J Med Genet. 1983 Feb;20(1):37-40. doi: 10.1136/jmg.20.1.37.
9
N-acetylation of drugs: search for INH acetylation polymorphism in baboons.药物的N-乙酰化：狒狒中异烟肼乙酰化多态性的研究
Drug Metab Dispos. 1979 May-Jun;7(3):194-5.
10
The use of the autoanalyzer to determine the acetylator phenotype.使用自动分析仪来确定乙酰化酶表型。
J Med Genet. 1972 Mar;9(1):57-9. doi: 10.1136/jmg.9.1.57.
引用本文的文献
1
Clinical perspectives of isoniazid-induced liver injury.异烟肼所致肝损伤的临床观点
Liver Res. 2021 Feb 11;5(2):45-52. doi: 10.1016/j.livres.2021.02.001. eCollection 2021 Jun.
2
Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.芳香胺 N-乙酰基转移酶乙酰化多态性：药物基因组指导治疗的范例——重点综述。
Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):9-21. doi: 10.1080/17425255.2021.1840551. Epub 2020 Nov 3.
3
Is Gene Polymorphism Associated with Vitiligo?基因多态性与白癜风有关吗？
Indian J Dermatol. 2020 May-Jun;65(3):173-177. doi: 10.4103/ijd.IJD_388_18.
4
The association between NAT2 acetylator status and adverse drug reactions of sulfasalazine: a systematic review and meta-analysis.NAT2 乙酰化状态与柳氮磺吡啶不良反应的关系：系统评价和荟萃分析。
Sci Rep. 2020 Feb 27;10(1):3658. doi: 10.1038/s41598-020-60467-8.
5
Effect of acetaminophen on sulfamethazine acetylation in male volunteers.对乙酰氨基酚对男性志愿者中磺胺二甲嘧啶乙酰化作用的影响。
Int J Immunopathol Pharmacol. 2016 Mar;29(1):17-22. doi: 10.1177/0394632015593238. Epub 2015 Oct 30.
6
PharmGKB summary: very important pharmacogene information for N-acetyltransferase 2.药物基因组知识库总结：N-乙酰转移酶2的非常重要的药物基因信息。
Pharmacogenet Genomics. 2014 Aug;24(8):409-25. doi: 10.1097/FPC.0000000000000062.
7
Acetylator phenotype and the clinical pharmacology of slow-release procainamide.乙酰化表型与普鲁卡因胺控释剂的临床药理学。
Br J Clin Pharmacol. 1976 Dec;3(6):1023-6. doi: 10.1111/j.1365-2125.1976.tb00352.x.
8
Phenelzine in urine: assay and relation to acetylator status.尿中苯乙肼的检测及其与乙酰化状态的关系。
Br J Clin Pharmacol. 1976 Aug;3(4):633-7. doi: 10.1111/j.1365-2125.1976.tb04887.x.
9
The relationship between the NAT2 phenotype polymorphism and predisposition to suicide in ethnic populations.N-乙酰转移酶2（NAT2）表型多态性与不同种族人群自杀易感性之间的关系。
Dokl Biochem Biophys. 2005 Sep-Oct;404:324-7. doi: 10.1007/s10628-005-0104-9.
10
The search for biochemical predictors of the NAT2 phenotype to optimize prophylaxis and pharmacotherapy of hepatic cirrhosis.寻找NAT2表型的生化预测指标以优化肝硬化的预防和药物治疗。
Dokl Biochem Biophys. 2005 Jan-Feb;400:52-5. doi: 10.1007/s10628-005-0031-9.
本文引用的文献
1
THE RELATIONSHIP BETWEEN THE CAPACITIES OF HUMAN SUBJECTS TO ACETYLATE ISONIAZID, SULFANILAMIDE AND SULFAMETHAZINE.
Life Sci (1962). 1965 Jan;4:99-107. doi: 10.1016/0024-3205(65)90040-8.
2
HUMAN ACETYLATION POLYMORPHISM.人类乙酰化多态性
J Lab Clin Med. 1964 Mar;63:394-403.
3
4
Genetic control of isoniazid metabolism in man.人体中异烟肼代谢的遗传控制。
Br Med J. 1960 Aug 13;2(5197):485-91. doi: 10.1136/bmj.2.5197.485.
5
Imperfection: biochemical phobias and metabolic ambivalence.缺陷：生化恐惧症与代谢矛盾心理
Perspect Biol Med. 1959;2(4):473-517. doi: 10.1353/pbm.1959.0037.
6
Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man.
J Pharmacol Exp Ther. 1965 Nov;150(2):298-304.
7
The actylation of sulamethazine and sulfamethoxypyridazine by human subjects.人对磺胺二甲嘧啶和磺胺甲氧哒嗪的乙酰化作用。
Clin Pharmacol Ther. 1968 Jan-Feb;9(1):80-8. doi: 10.1002/cpt19689180.
Zotero 插件